Bay City Capital — 2017 Investments
2 investments dated 2017 · listed companies and verified rows first · show all
EnteroMedicsMay 2017
HealthtechSt Paul, US
Gary D Blackford(Director)Dan W Gladney(Executive Officer, Director)Scott P Youngstrom(Executive Officer)Rajesh Nihalani(Executive Officer)Peter M DeLange(Executive Officer)Bobby I Griffin(Director)
Board seatCarl Goldfischer· per SEC Form D
Xeris PharmaceuticalsMay 2017
BiotechAustin, US
Robert Faulker(Director)Poul Strange(Executive Officer)Navneet Puri(Director)Steven Prestrelski(Executive Officer)Cary McNair(Director)Douglas Baum(Executive Officer, Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.